Wendi Guo

Wendi Guo, Ph.D., is a Health Outcomes Liaison in Immunology at Eli Lilly and Company, where they partner with healthcare stakeholders to translate evidence into impactful strategies for patient care. They hold a Ph.D. in Pharmacology from Duke University, where they published over 15 scientific articles and secured a $1.75 million grant for osteoporosis research. Wendi's previous roles include serving as an Associate Life Sciences Consultant at Alkemi and as a Technology Transfer Fellow at Duke's Office for Translation & Commercialization, where they evaluated inventions for market potential. They also have experience in academic research, having worked as a Student Researcher at Emory University and a Research Assistant at the Medical College of Georgia.